Shirkad Israa’iili ah oo ka shaqaysa AI, Converge Bio, ayaa uruursatay $25M si ay u beddesho daahfurka dawooyinka
Shirkad Israa'iili ah oo sameysa AI oo la yiraahdo Converge Bio ayaa heshay maalgelin $25 milyan oo doolar oo ah Series A, taasoo ka dhigaysa wadarta $30M ee madal ay ku sahaminayso dawooyinka oo ay isticmaalayso AI.